A new canalith repositioning procedure for posterior canal short-arm type of benign paroxysmal positional vertigo

JRCT ID: jRCT1071230105

Registered date:10/01/2024

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Some subjects may experience neck pain or stiff shoulders due to parietal position method.
• Date of first enrollment: 10/01/2024
• Target sample size: 60
• Study type: Interventional
• Intervention(s): Patients with posterior canal BPPV (short-arm type) will be randomly assigned to two groups: one group performes the parietal position method and takes anti-vertigo medication (3 tablets of betahistine mesylate tablets, 6 mg, three times a day, after each meal, for 3 days), and the other group takes anti-vertigo medication alone. The disappearance of positional nystagmus on the day after the test will be compared between these two groups.

Outcome(s)

• Primary Outcome: Disappearance of positional nystagmus on the day after the test
• Secondary Outcome: Reduction of perceived intensity of positional vertigo (Visual analogue scale)

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: Not applicable

Include criteria

1. Adults over 18 years old
2. Patients with posterior canal BPPV (short-arm type)

Exclude criteria

1. Patients with chronic headache, neck pain, or lower back pain
2. Patients with a history of cervical or lumbar spine disease, heart disease, Meniere disease or central disease
3. Patients suspected of having retinal disease such as retinal detachment

Related Information

• Primary Sponsor: Shigeno Kohichiro